ThePODdoctors are Dr. Damien Dauphinee, double board certified in Reconstructive Foot and Ankle Surgery and Wound Management and his partner Dr. Raafae Hussain, fellowship trained podiatric surgeon. Each week ThePODdoctors will be discussing aspects of podiatric medicine and surgery to educate our audience on common foot and ankle problems and the latest treatment options available.
The PODdoctors with Dr. Dauphinee and Dr. Hussain
Claim This Podcastby Dr. Damien Dauphinee and Dr. Raafae Hussain
4.9(17 reviews)
71 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇨🇦
Podcast Overview
ThePODdoctors are Dr. Damien Dauphinee, double board certified in Reconstructive Foot and Ankle Surgery and Wound Management and his partner Dr. Raafae Hussain, fellowship trained podiatric surgeon. Each week ThePODdoctors will be discussing aspects of podiatric medicine and surgery to educate our audience on common foot and ankle problems and the latest treatment options available.
Language
🇺🇲
Publishing Since
11/18/2020
Reach the team behind The PODdoctors with Dr. Dauphinee and Dr. Hussain
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
April 17, 2026
The Magic Trick in Peripheral Nerve Surgery: Tulavi's Allay Hydrogel Cap
<p>Episode Description: Dr. Damien Dauphinee sits down with Josh Vose, CEO of Tulavi Therapeutics, and Andrea Para, Senior Director of Medical Affairs and Strategy, to explore a breakthrough in peripheral nerve surgery. The conversation covers how the Allay Hydrogel Cap is transforming neuroma treatment with a sutureless, resorbable technology that delivers dramatic pain relief and puts advanced nerve care within reach of every surgeon.</p><p></p><p>Key Takeaways:</p><p></p><p>● The Allay Hydrogel Cap received de novo FDA classification in July 2024, representing a new category of in-situ forming nerve cap technology distinct from traditional biologic caps</p><p></p><p>● In a retrospective multicenter analysis of 23 patients, no neuroma formation was observed in either prophylactic or therapeutic groups, with an average pain score reduction of 5.5 points</p><p></p><p>● The sutureless application eliminates the need for microsurgery training, enabling general surgeons and non-fellowship-trained physicians to achieve outcomes previously limited to microsurgical specialists</p><p></p><p>● Traditional neuroma treatments like TMR show only 50% pain reduction and 25% cure rates in revision cases, while early Allay results are demonstrating superior and more consistent outcomes</p><p></p><p>● Patients are discontinuing opioids within days of surgery, a finding replicated across multiple surgical sites and a significant departure from typical post-neurectomy recovery</p><p></p><p>● The hydrogel is 90% water, remains stable for three to four months past the neuroma formation window, and fully hydrolyzes within eight months, leaving no scarring or remnants</p><p></p><p>● Surgeons should dissect back to normal, healthy nerve tissue before capping, and ensure adequate nerve length to position horizontally in the form for optimal gel application</p><p></p><p>● The "unmasking phenomenon," where resolving dominant nerve pain reveals secondary musculoskeletal or nerve issues, is common and requires careful patient counseling and precise post-op pain assessment</p><p></p><p>● Tulavi is expanding into TMR applications, pediatric use (patients over 25 kg), and has pipeline products targeting nerve repair expected in early to mid-2027</p><p></p><p>Guest Info:</p><p></p><p>Josh Vose, MD, MBA</p><p>CEO, Tulavi Therapeutics</p><p>Background: Chemical engineer (Georgia Tech) turned surgeon-operator with 25+ years building peripheral nerve and surgical device startups. MD from the Medical College of Georgia in Augusta; general surgery training in Boston. Former CEO of Peak Surgical (Plasma Blade, acquired by Medtronic) and Sia (resorbable mesh for breast reconstruction, acquired by Integra). Joined Tulavi to commercialize the Allay Hydrogel Cap and scale peripheral nerve solutions beyond microsurgery-only centers.</p><p>LinkedIn: https://www.linkedin.com/in/josh-vose-7306661</p><p>Website: www.tulavi.com</p><p></p><p>Andrea Para, PhD</p><p>Senior Director of Medical Affairs and Strategy, Tulavi Therapeutics</p><p>Background: Medtech strategist, patient advocate, and bioengineer with 14+ years across medtech R&D, hospital and medtech consulting, and strategic planning. BS, MS, and PhD in Bioengineering from Georgia Tech, where her doctoral thesis under Dr. David Ku focused on preventing rapid platelet accumulation under very high shear stress. Previously Director of Exploration at Edwards Lifesciences, Sr. Manager for Product Development and Strategy at Accenture, Consulting Director at Vizient, and R&D Engineer II at St. Jude Medical working on next-generation heart valves. Also Principal/CEO of Medivici LLC, providing technical due diligence for medical device and IVD investors. Joined Tulavi in November 2025.</p><p>LinkedIn: https://www.linkedin.com/in/andrea-para</p><p>Website: www.tulavi.com</p><p></p><p>Resources:</p><p></p><p>● "Saving Limbs, Saving Lives: Advanced Treatments to Prevent Amputations in Diabetic Populations" by Dr. Damien Dauphinee (Kindle): www.amazon.com</p><p>● Tulavi Therapeutics: www.tulavi.com</p><p>● Dr. Eddie Cobray's publication on first 11 patients with Allay Hydrogel Cap (published approximately four months before recording)</p><p>● American Society of Peripheral Nerve (ASPN) abstract: retrospective multicenter analysis of 23 patients</p><p>● Vizient Innovative Technology Contract: www.vizientinc.com</p><p>● Association of Extremity Nerve Surgeons (AENS): www.aens.us</p><p>● Incept (medtech accelerator, parent company family of Tulavi)</p><p>● Gerson Lehrman Group (GLG): www.glg.it</p><p></p><p>Connect:</p><p></p><p>● The Pod Doctors: www.thepoddoctors.com</p><p>● The Pod Doctors on Spotify, Apple Podcasts, Stitcher, and YouTube</p><p>● Tulavi Therapeutics: www.tulavi.com</p><p>● The Pod Doctors on Facebook and Twitter</p><p></p><p>#ThePodDoctors #Podiatry #FootAndAnkle #PodiatricMedicine #WoundCare #DiabeticFootCare #PeripheralNerve #Neuroma #FootSurgery #LimbPreservation #TulaviTherapeutics #AllayHydrogelCap #NerveCap #PeripheralNerveSurgery #NeuromaTreatment #MedicalDevices #SurgicalInnovation #PainManagement #OpioidReduction #Neurectomy</p>
December 26, 2025
The Future of Wound Healing: Pain Guard with Brad Wiggins and Dr. Victoria Miles
<p>In this episode of The PODdoctors podcast, Dr. Damien Dauphinee explores the latest innovations in wound care technology, with a spotlight on SAM (Synthetic Antimicrobial Matrix), a breakthrough solution that integrates lidocaine for effective pain management. Joined by Dr. Victoria Miles and Brad Wiggins from Imbed Biosciences, we discuss how this cutting-edge technology is reshaping burn care and podiatric surgery. The conversation highlights SAM’s dual-action approach, supporting wound healing while delivering meaningful pain relief, leading to improved postoperative outcomes and a reduced reliance on opioid medications. </p><p>Listen as they examine how innovation and evidence-based medicine come together to elevate patient care and improve quality of life.</p><p><strong>Top Takeaways:</strong></p><ul><li>Introduction to SAM (Synthetic Antimicrobial Matrix) and its role in next-generation wound care</li><li>How lidocaine integration enhances pain management at the wound site</li><li>Insights from Dr. Victoria Miles and Brad Wiggins of Embed Biosciences</li><li>Applications of SAM technology in burn care and podiatric surgery</li><li>Benefits of a dual-action matrix: accelerated healing and meaningful pain relief</li><li>Impact on postoperative outcomes and reduced reliance on opioid medications</li><li>The importance of clinical research and early case studies in validating new technologies</li><li>Real-world patient experiences demonstrating improved comfort and recovery</li><li>The future of wound care innovation and its role in improving patient quality of life</li></ul><br/><p><strong>Resources:</strong></p><p>Visit our website:<a href="https://thepoddoctors.com/" rel="noopener noreferrer" target="_blank"> https://thepoddoctors.com/</a></p>
November 8, 2024
Plantar Fibroma
Board-certified surgeon Dr. Damien Dauphinee and fellowship-trained surgeon Dr. Raafae Hussain discuss plantar fibromas, highlighting the importance of addressing these benign tumors before they lead to complications.
71 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for The PODdoctors with Dr. Dauphinee and Dr. Hussain
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is The PODdoctors with Dr. Dauphinee and Dr. Hussain?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.